Chinese firm Insilico to test AI-developed drug By Cheng Yu | chinadaily.com.cn | Updated: 2021-03-05 14:26 Share [Photo/IC]
Insilico Medicine, a Chinese investors-backed company that uses artificial intelligence to develop new drugs, said that its chemical compound candidate is likely to enter into clinical trials by the end of this year, according to its top executives. We expect our chemical compound candidate to start its first clinic trial by the end of the end before the second and third trials, said Ren Feng, chief science officer at Insilico Medicine. (Once finished), it will be the first time that the world uses AI to find new targets, discover new compounds, and makes into the clinical period, which will be a milestone, Ren said.
China
Qiming
Sichuan
Ren-feng
Fujian
Chinese
Liang-yingyu
Alex-zhavoronkov
Sinovation-ventures
Qiming-venture-partners
Ai